Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transfusion Reaction | 9 | 2023 | 46 | 2.420 |
Why?
|
| Blood Component Removal | 6 | 2021 | 11 | 1.370 |
Why?
|
| Checklist | 2 | 2023 | 74 | 1.010 |
Why?
|
| Students, Nursing | 2 | 2023 | 72 | 0.950 |
Why?
|
| Blood Transfusion | 7 | 2023 | 147 | 0.910 |
Why?
|
| Nursing Education Research | 1 | 2023 | 28 | 0.890 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2023 | 39 | 0.850 |
Why?
|
| Patient Safety | 4 | 2023 | 235 | 0.810 |
Why?
|
| Blood Safety | 3 | 2023 | 4 | 0.460 |
Why?
|
| Societies, Medical | 3 | 2021 | 326 | 0.430 |
Why?
|
| Medical Staff Privileges | 1 | 2012 | 9 | 0.420 |
Why?
|
| Blood Group Incompatibility | 2 | 2012 | 10 | 0.420 |
Why?
|
| Credentialing | 1 | 2012 | 15 | 0.420 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 58 | 0.410 |
Why?
|
| Vital Signs | 1 | 2012 | 11 | 0.400 |
Why?
|
| Blood Volume | 1 | 2012 | 42 | 0.390 |
Why?
|
| Chlamydophila pneumoniae | 2 | 2006 | 21 | 0.340 |
Why?
|
| Plateletpheresis | 1 | 2006 | 4 | 0.280 |
Why?
|
| Telemedicine | 2 | 2021 | 330 | 0.260 |
Why?
|
| ADAMTS13 Protein | 1 | 2024 | 6 | 0.230 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2024 | 9 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2023 | 669 | 0.230 |
Why?
|
| Nursing Evaluation Research | 1 | 2023 | 38 | 0.220 |
Why?
|
| Humans | 21 | 2024 | 59078 | 0.200 |
Why?
|
| Anemia, Sickle Cell | 1 | 2022 | 65 | 0.190 |
Why?
|
| Adult | 8 | 2024 | 15680 | 0.170 |
Why?
|
| Acute Lung Injury | 1 | 2018 | 39 | 0.150 |
Why?
|
| Evidence-Based Nursing | 1 | 2017 | 12 | 0.150 |
Why?
|
| Critical Care Nursing | 1 | 2017 | 17 | 0.140 |
Why?
|
| Blood Donors | 2 | 2006 | 21 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2023 | 3080 | 0.130 |
Why?
|
| Female | 9 | 2024 | 30709 | 0.120 |
Why?
|
| Young Adult | 1 | 2023 | 4303 | 0.110 |
Why?
|
| Male | 7 | 2023 | 27399 | 0.110 |
Why?
|
| Pulmonary Edema | 1 | 2013 | 25 | 0.110 |
Why?
|
| Anemia, Aplastic | 1 | 2013 | 10 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 701 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 61 | 0.110 |
Why?
|
| Algorithms | 1 | 2018 | 985 | 0.110 |
Why?
|
| Consultants | 1 | 2012 | 12 | 0.100 |
Why?
|
| Physician Executives | 1 | 2012 | 28 | 0.100 |
Why?
|
| Respiratory Rate | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 173 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 98 | 0.100 |
Why?
|
| Fever | 1 | 2012 | 63 | 0.100 |
Why?
|
| Documentation | 1 | 2012 | 127 | 0.100 |
Why?
|
| Fluid Therapy | 1 | 2012 | 53 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2011 | 23 | 0.090 |
Why?
|
| Heart Rate | 1 | 2012 | 303 | 0.090 |
Why?
|
| Safety | 2 | 2007 | 140 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2012 | 519 | 0.080 |
Why?
|
| Plasma Exchange | 2 | 2024 | 20 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2012 | 837 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 419 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 1098 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2006 | 4 | 0.070 |
Why?
|
| Platelet Transfusion | 1 | 2006 | 13 | 0.070 |
Why?
|
| Blood Specimen Collection | 1 | 2006 | 19 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5062 | 0.070 |
Why?
|
| Automation | 1 | 2006 | 58 | 0.070 |
Why?
|
| Heart Failure | 1 | 2013 | 860 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 16197 | 0.060 |
Why?
|
| Leukocytes | 1 | 2006 | 107 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 453 | 0.060 |
Why?
|
| Safety Management | 1 | 2007 | 142 | 0.060 |
Why?
|
| Chlamydia | 1 | 2005 | 10 | 0.060 |
Why?
|
| United States | 2 | 2021 | 7461 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2005 | 97 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2017 | 5952 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 244 | 0.060 |
Why?
|
| Chlamydia Infections | 1 | 2005 | 77 | 0.060 |
Why?
|
| Antigen-Antibody Complex | 1 | 2024 | 49 | 0.060 |
Why?
|
| Blood Banks | 1 | 2023 | 9 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2024 | 174 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2022 | 32 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2024 | 691 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 50 | 0.050 |
Why?
|
| Aged | 2 | 2017 | 13267 | 0.050 |
Why?
|
| Asthma | 1 | 2005 | 416 | 0.050 |
Why?
|
| Mobile Health Units | 1 | 2020 | 10 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2019 | 32 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2021 | 176 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2020 | 402 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 4990 | 0.040 |
Why?
|
| Medical Errors | 1 | 2020 | 181 | 0.040 |
Why?
|
| Massachusetts | 1 | 2023 | 2082 | 0.040 |
Why?
|
| Babesiosis | 1 | 2014 | 10 | 0.030 |
Why?
|
| Urticaria | 1 | 2014 | 6 | 0.030 |
Why?
|
| Whooping Cough | 1 | 2014 | 15 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2014 | 60 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2014 | 153 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 5129 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 169 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2014 | 106 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 62 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 455 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 337 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 880 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 731 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2571 | 0.020 |
Why?
|
| Sepsis | 1 | 2014 | 279 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 904 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 310 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1220 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2011 | 170 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 291 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1985 | 0.020 |
Why?
|
| Adolescent | 2 | 2011 | 5897 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2007 | 11 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 3183 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2053 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2005 | 31 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 85 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 398 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 667 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 498 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 2883 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1307 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1518 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1824 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10232 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 2430 | 0.010 |
Why?
|
| Child | 1 | 2005 | 4260 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 19554 | 0.010 |
Why?
|